US Stock MarketDetailed Quotes

Bristol-Myers Squibb (BMY)

Watchlist
  • 58.220
  • -2.370-3.91%
Close May 1 16:00 ET
  • 58.500
  • +0.280+0.48%
Post 19:59 ET
118.89BMarket Cap16.31P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Bristol-Myers Squibb (BMY) Revenue Breakdown Overview

By Business/Source

Currency:USD
2025/FY
Stock NameRevenueRatio
Eliquis14.44B29.97%
Opdivo10.05B20.85%
Other5.81B12.04%
Orencia3.71B7.69%
Revlimid2.95B6.12%
Yervoy2.9B6.02%
Pomalyst/Imnovid2.73B5.67%
Reblozyl2.33B4.83%
Other Growth products1.92B3.99%
Breyanzi1.36B2.82%
View all

By Country/Region

Currency:USD
2025/FY
Stock NameRevenueRatio
United States33.28B69.05%
International13.83B28.69%
Other1.09B2.26%
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +17.90%
Sample Name
Sample Code
 +13.59%
Sample Name
Sample Code
 +12.81%
4
VanEck Oil Services ETF
OIH
+11.45%
5
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
+9.96%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +11.87%
Sample Name
Sample Code
 +6.69%
Sample Name
Sample Code
 +6.27%
4
KE Holdings
BEKE
+5.44%
5
New Oriental
EDU
+4.10%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On May 1, the more than two-month-long military conflict involving the US, Israel, and Iran will reach a legal milestone, potentially increa Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -